• Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
  
• Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
  

PubMed=10992426; DOI=10.1016/S0022-5347(05)67210-2
Belur Janakray Patel, Allan Jonathan Pantuck, Amnon Zisman, Ke-Hung Tsui, Sun H. Paik, Randy Caliliw, Scott Sheriff, Lily Wu, Jean B. deKernion, Cho-Lea Tso, Arie S. Belldegrun;
CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
J. Urol. 164:1420-1425(2000)

PubMed=11038142
Cho-Lea Tso, William H. McBride, Ji-Rong Sun, Belur Janakray Patel, Ke-Hung Tsui, Sun H. Paik, Barbara Gitlitz, Randy Caliliw, Arndt van Ophoven, Lily Wu, Jean B. deKernion, Arie S. Belldegrun;
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Cancer J. Sci. Am. 6:220-233(2000)

PubMed=15162376; DOI=10.1002/pros.20031
Alvin Y. Liu, Kristen D. Brubaker, Young Ah Goo, Janna E. Quinn, Sabine Kral, Carrie M. Sorensen, Robert Louis Vessella, Arie S. Belldegrun, Leroy Edward Hood;
Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines.
Prostate 60:98-108(2004)

PubMed=15833837; DOI=10.1158/0008-5472.CAN-04-3218
Biao-Yang Lin, James T. White, Wei Lu, Tao Xie, Angelita Gaoiran Utleg, Xiao-Wei Yan, Eugene C. Yi, Paul Shannon, Irina Khrebtukova, Paul Henry Lange, David Robinson Goodlett ...Show all 14 authors... , Dai-Xing Zhou, Thomas Josepth Vasicek, Leroy Edward Hood; Show fewer authors
Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease.
Cancer Res. 65:3081-3091(2005)